regulatory lobbying and public awareness campaigns, it supports the wide variety of work necessary to introduce non-animal testing methods, get them accepted by regulatory bodies, and support young researchers in their future careers. What makes the Lush Prize completely unique is that it is a 'One R' prize, supporting absolute replacement of animal testing. It remains the largest prize fund in this area.
Each of the five prize categories has £50,000 funding. For any year in which there is a key breakthrough in human toxicity pathways research, the full £250,000 will be awarded (the Black Box Prize). Having selected Black Box Prize winners in 2015, with the £250,000 prize money provided, as usual, by Lush Cosmetics in the UK, we were extremely fortunate that Lush North America offered another £200,000 to ensure that we could still provide awards to winners in the other five categories. The £450,000 prize money given in 2015 brings the total financial rewards since the Lush Prize began to £1.2million, to support initiatives to end animal testing.
However, this is more than just about providing funds, as important as that is. Each year, a conference is organised to discuss key topics around the subject of animal testing, research papers are produced to highlight main activities and stakeholders in the different prize categories, and outreach is conducted with target audiences. With our first ever Black Box Prize winners, the 2015 conference was themed around Adverse Outcome Pathways in toxicity testing.
Also important is the unique opportunity to bring together stakeholders who do not often get the chance to meet and talk about animal testing and the hugely varying activities they do to support scientifically and ethically more-valid alternatives. This year saw 18 winners from nine countries, as far apart as New Zealand, Brazil, the Ukraine and the USA.
The Lush Prize is managed on a day-to-day basis by a three-person team at Ethical Consumer Research Association (ECRA) and is overseen by a management committee comprising the Lush Prize Team and two people from Lush. The 2015 committee were Rob Harrison, Rebecca Ram and Craig Redmond from ECRA, and Karl Bygrave and Hilary Jones from Lush. Karen Huxley, Head of Global PR at Lush, also gave significant input to the project.
The Prize Categories
There are five separate award categories, each carrying a £50,000 prize. In addition, the Black Box Prize offers the full £250,000 for a key breakthrough in human toxicity pathway research. In 2015, the £250,000 was awarded to five Black Box Prize winners, and an additional £200,000 was used to fund the other five categories.
Science Prize
For individuals, research teams or institutions for work conducted on relevant toxicity pathways. Outstanding research producing an effective nona Kelly BéruBé is a member of the Lush Prize judging panel; b Craig Redmond is part of the Lush Prize management committee. animal safety test based on an approach other than toxicity pathways, where none existed before, may also be considered.
Training Prize
For individuals, teams or organisations involved in training others in non-animal methods. Many established scientists may not have been trained in, or be aware of, alternative methods, while future scientists and students need to be provided with education in alternatives, in order to be able to pursue further research in this area. Establishing training programmes and increasing capacity, whether as one-off workshops or ongoing programmes, can make a huge difference in this field.
This prize recognises the importance of dissemination of methods among commercial scientists, researchers and students. The criteria for training are broad, and include training existing scientists in new techniques, open-source databases, and the education of school children.
Young Researcher Prize
Open to keen young scientists (up to 35 years at the time of application) with a desire to fund the next stage of a career focused on an animal-test free future. Because toxicology has for so long been centred on animal testing, many scientists with concerns about the use of animals are deterred from becoming toxicologists. Those who do enter the field can find that access to funding for working on non-animal tests can be a barrier. We want to change this, and to encourage young scientists to develop a career in toxicology without harming animals, through offering bursaries to allow them to advance in this area.
Lobbying Prize
This Prize aims to reward the work of exceptional individuals, groups or organisations pushing for change, focusing on policy interventions promoting the use of alternatives. It is a One R prize, seeking projects working on replacement (rather than reduction and refinement), and avoids funding projects or initiatives linked to animal testing in other ways.
Scientific innovation needs to go hand-in-hand with policy change to ensure that the end-users of new testing approaches -industry and regulators -are receptive and responsive to the new methods.
Public Awareness Prize
Recognising that, despite years of campaigning, animal testing still continues, this prize is aimed at rewarding individuals or organisations who increase public awareness of ongoing animal testing.
Partial legislative victories have led to the common misconception that animal testing, especially for cosmetics, no longer takes place. Therefore, it is vital that the public are reminded that this cruel and unscientific practice does continue in many areas of the world. Support is essential for public awareness activities, to ensure that this issue remains high on the political agenda.
Black Box Prize
The Black Box Prize offers, in any one year, the full £250,000 Lush Prize fund for a key breakthrough in human toxicity pathways research.
The aim of the Black Box Prize is to stimulate a worldwide research and training focus on human toxicity pathways, with the accompanying development of human biology-based assays, and of the computational tools (e.g. systems biology approaches, physiologically-based pharmaco kinetic models and in vitro-in vivo extrapolation techniques) needed to replace the use of animals in toxicology. This would drive forward the 21st century culture change in the world of toxicology research and training that has already started as a result of the US National Research Council's 2007 report. 1 The Lobbying, Public Awareness, Science and Training awards are all retrospective, in that they are for projects that have been running in the 18 months preceding the prize award. The Young Researcher Prize is different in that it is to fund future research. For the Black Box Prize, research should have been completed and published within five years prior to the award. It is the only category for which nominations cannot be made. Allocation of a winner is at the discretion of the judges, based on both their knowledge of the current situation and research carried out by the Prize Team.
Global Reach of the Prize
The Lush Prize has always been a global prize, open to anyone in any country, as long as their work meets the criteria. As time progresses and the initiative becomes more widely known, so the nominations arrive from a wider range of countries.
Fifty-six scientists and organisations in 22 countries have so far benefited from £1.2 million of Lush Prize funding for 'outstanding contributions' to replace animal testing. The winners in 2015 came from nine countries; we again had a Young Researcher winner from Brazil, which shows the increasing interest in alternatives there, as well as a Training Prize winner from the Ukraine. Short -listed nominees included applicants from Belarus, Malaysia and South Korea, showing that our outreach efforts are succeeding in getting through to a global-wide audience.
In addition, judges are selected both for their own individual expertise and to ensure they represent a varied geographical range. The seven judges in 2015 were based in Brazil, Canada, Denmark, the UK and the USA.
Although the Lush Prize website is primarily in English, many sections are also currently available in eight other languages. There are plans to improve and extend this, to make it easier for those who are less confident in the use of English to access the site and to submit nominations in their chosen language.
With the support of the global PR teams at Lush Cosmetics, outreach and media work is conducted in as many countries as possible. The Lush Prize Team also attends appropriate conferences. In 2015, these included EUROTOX 2015 (51st Congress of the European Society of Toxicology) in Portugal, the EUSAAT conference in Austria, and the Dr Hadwen Trust Animal Replacement Science Conference in the UK.
Eligibility criteria
The Lush Prize is different to many other funding opportunities in the field of alternatives to animal testing, in that it is a One R rather than Three R prize. Lush Prize only fund projects that work to replace, rather than reduce or refine, animal experiments.
Non-animal research in this sense means no use of non-human animals (including all vertebrates and invertebrates) or primary animal cells, embryos, tissues, organs and sera. Human biology-based approaches are strongly encouraged, although the use of established cell lines of non-human animal origin will not necessarily be excluded.
Any nominees for the three science-based categories are asked to clarify whether they have conducted any animal-based research in recent years, and this will be taken into account by the judges.
Transparency
The Lush Prize prides itself on the transparent way in which it operates. Although funded entirely by Lush Cosmetics, the management of the Prize is conducted by Ethical Consumer Research Association. ECRA is an independent, not-for-profit, multi-stakeholder co-operative with open membership, which conducts research with the aim of making global business more sustainable through consumer pressure.
Decisions with regard to winners of the prizes are made by the independent panel of judges, not by Lush Prize, ECRA or Lush Cosmetics. The judges are selected for their expertise in the areas of animal testing, alternatives, science, regulatory processes, and public awareness related to animal protection. New judges are often added, and we aim to have judges representing various geographical areas, which affords the panel greater understanding of the research and the campaigns, as well as the quality of nominations, in those regions. Crucially, it encourages more nominations from countries which previously had been under-represented.
It is inevitable that nominations are occasionally submitted on behalf of organisations/science teams which the judges work for, or students who they supervise. In these cases, the individual judge leaves the room and takes no part in discussions about that nomination. Impartiality is crucial for both the success and transparency of the Lush Prize.
The 2015 Lush Prize Conference

Conference theme: Adverse Outcome Pathways
With the potential for having the first ever Black Box Prize winners, we focused on the concept of Adverse Outcome Pathways (AOPs). These pathways are sequences of cellular events that occur when a substance interacts with the body. They offer the potential to greatly improve the prediction of human health effects, and to end the use of animals in toxicity testing. The first recognised AOP is for skin sensitisation, and the assays involved are currently undergoing regulatory approval. The 2015
Conference theme assessed what further work needs to be done, and where research and innovation in the area of AOPs is heading.
The Lush Prize judges believe that mapping the 'human toxicity pathway' represents a breakthrough moment, marking the first step into a future where a superior molecular science replaces the old, imprecise technology of testing on animals in laboratories. In 2015, the Black Box Prize was awarded for the first time, and recognises the work conducted on the AOP for skin sensitisation, by five teams or individuals.
Conference highlights
From what began simply as a platform for prize winners to describe their work, the Lush Prize Conference has become a respected event in its own right. Under the theme Adverse Outcome Pathways -What, How and Where Next?, the conference was introduced as follows:
When the US government published its 2007 report on 21st Century Toxicology, it predicted that understanding adverse outcome pathways at a molecular level would sweep away old, imprecise, technologies like testing on live mammals in laboratories.
With the first pathway (for skin sensitisation) now mapped, is that early excitement still maintained? Or has the whole complexity of the project been underestimated? Is the dream of a future with no animals used in toxicity testing still in sight? Or is it likely to remain distant for many years to come?
The first session, chaired by Dr Gill Langley of Humane Society International (and also one of the Lush Prize judges), featured presentations from the Black Box Prize winners about their work on the skin sensitisation AOP.
The Conference programme noted:
We are delighted to welcome such a distinguished platform of speakers into what for them, with our 1R focus, will be an unusual environment. Our Black Box Prize winners include people working inside some very big and potentially controversial organisations including Givaudan and Procter & Gamble. Lush Prize is committed to rewarding research excellence on pathway-based approaches to understanding toxic effects wherever it occurs. We hope today will bring a respectful debate and help us exchange ideas around the linked ideas of 21st Century Toxicology and 1Rs (animal replacement science).
Winners across all prize categories presented their projects at sessions throughout the day, and the conference finished with speakers and a Q&A session on AOPs and their role on the replacement of animals in product safety testing, an issue at the core of the Lush Prize remit.
We were also fortunate to receive Professor Cheng Shujun, Director of the Toxicology Depart ment, Guangdong Inspection & Quarantine Bureau, and Founder of the Chinese Centre for Alternatives Research & Evaluation, who provided an update on alternatives to animal testing in China.
Most of the presentations provided by speakers at the conference, as well as videos of some of them, are available on our website (http://www.lushprize. org/2015prize/2015-conference/).
Lush Prize Winners
Black Box Prize -The OECD's Adverse Outcome Pathway programme, France, accepted by Bob Diderich (£150,000) . The programme oversees a range of activities, including: identifying new non-animal test methods that are candidates to become international 'Test Guidelines' and managing an 'AOP Knowledge Base', which is a web-based platform to bring together all knowledge on how chemicals can induce adverse effects.
-David Basketter, UK (£25,000). David is a UKbased researcher, who has published over 300 papers on skin sensitisation, bridging the gap between industry and academic research. He has focused particularly on trying to predict whether chemicals will cause allergy from their molecular structure, and has also chaired important European groups focused on nonanimal tests.
-Frank Gerberick, USA (£25,000). Frank's primary research focus has been in the field of skin allergy, with over 170 publications. His laboratory at Procter & Gamble in the USA has developed one of the first widely-used non-animal tests (the Direct Peptide Reactivity Assay [DPRA]) to predict toxicity at the first stage in the skin sensitisation pathway. He donated his financial reward to the Humane Society International's End Animal Testing programme.
-Andreas Natsch and Roger Emter, Switzerland (£25,000). Andreas and Roger have led the development of the second non-animal test to reliably predict toxicity within the skin sensitisation pathway. Their KeratinoSens® method, developed in the Givaudan laboratories in Switzerland, uses a human cell line in a test tube, and is based on a particular type of gene signalling.
-Terry Schultz, USA (£25,000). Terry is emeritus professor at the University of Tennessee, where he directed the Biological Activity Testing and Modelling Laboratory. His focus has been the non-animal testing of chemicals for toxicity, and building computer databases of results to help predict outcomes. He played a key role in mapping the whole pathway in two OECD publications in 2012. 2, 3 Lobbying -Mojo Mathers MP, New Zealand (£10,000). A Green Party MP, Mojo has been a leading figure in the political campaign to ban cosmetics testing on animals in New Zealand. In April 2015, the New Zealand Government passed a ban on the animal testing of both finished cosmetics and of ingredients exclusively used for cosmetics. Mojo very kindly declined the finan-cial part of the Lush Prize for Lobbying, allowing the judges to award it to an additional Young Researcher, to assist in a career in science without the use of animals.
Public Awareness
-SOKO Tierschutz EV, Germany (£20,000). SOKO Tierschutz's campaign against primate research at the Max-Planck-Institute for Biological Cybernetics in Tübingen, Germany, was based on a groundbreaking undercover investigation that documented -for the first time in Europe -the reality behind invasive experimental brain research on primates.
-Beagle Freedom Project, USA (£20,000). Awarded for its Identity Campaign to highlight the suffering of dogs and cats in taxpayer-funded laboratories in the USA, and to encourage the public to use freedom of information legislation to advocate on behalf of those animals. 
Science
Young Researcher
All Young Researcher winners receive £10,000. This year we were able to fund an additional Young Researcher with the prize money transferred from the Lobbying Prize.
-Laura Bray, Leibniz Institute of Polymer Research, Germany. For a proposed project to provide three key developments to animal replacement in cancer research and patients: a toolbox for medical researchers to study acute myeloid leukaemia in vitro; a method for highthroughput drug screening to accelerate clinical trials; and a model system to test patient blood samples, for the purpose of individualising their treatment programme.
-Jeremy Caplin, Hashemi Labs, Iowa State University, USA. For the design and use of a 'placenta-on-a-chip'. This chip is a 3-D microfluidic device that serves as an improved method for drug testing and toxicology. The 'placenta-ona-chip' utilises microfluidic technology, in order to replicate organ functions in the cotyledon section of the placenta. This design is different from other current organ-on-a-chip methods, in that all use of animal products will be eliminated.
-Elena Kummer, Università degli Studi di Milano, Italy. For work contributing to understanding the extent and quality of allergic sensitisation. The goal is to provide a simple assay, based on the use of a commercially available cell lines able to provide potency information, which is required for full replacement of animals in the assessment of the allergenic potential of xenobiotics.
-Bianca Marigliani, The Federal University of São Paulo, Brazil. For research to replace the use of the fetal bovine serum (FBS) obtained from fetuses during the slaughter of pregnant cows. FBS is the most common animal-derivative used as a medium supplement, but ethical and technical problems are associated with its use. The replacement of FBS and other animalderived products in alternative in vitro methods is a step further toward a real animal-free future in hazard assessment.
-Ilka Maschmeyer, TissUse, Germany. For work on the long-term systemic interconnection of different organs with each other, focusing on the skin tissue, providing the dermal application route for cosmetics and drugs, and replacing animal tests. TissUse provides a multiorgan-chip platform, which permits the chronic testing of the effects of substances on a set of miniaturised human organs, replacing animal models.
-Lena Smirnova, Center for Alternatives to Animal Testing, USA. For research on a 3-D organotypic human in vitro brain model, developed in combination with multi-omics technologies for (developmental) neurotoxicity testing (DNT). The research goal is to establish a highthroughput testing platform for in vitro chemical testing.
Comments and Feedback
We welcome any comments on how we can improve the Lush Prize. Although we already conduct evaluative surveys with prize winners and those attending the conferences, we appreciate any additional feedback. If you would like to speak to us, please contact Craig Redmond (contact details below).
Dr Kelly A. BéruBé Cardiff School of Biosciences
